1Bharadwaj A, Haroon N. Peripheral neuropathy in patients on leflunonfide[J]. Rheumatology, 2004,43(7) :934.
2Smolen JS, Kalden JR, Scott DL, et al. and the European leflunomide study group. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis : a double blind, randomised, multicentre trial[J]. Lancet, 1999,353 (9 149) : 259-266.
3Richards BL, Spies J, McGill N, et al. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis [ J ]. Internal Medicine Journal, 2007,37(2):101-107.
4Thomas K, Toyka HP, Jung S. Suppression of experimental autoimmune neuritis by leflunomide[J] .Brain,2001,124(9):1 791-1 802.
5Peltier AC, Russell JW. Recent advances in drug-induced neuropathies [J]. Curr Opin Neurol, 2002,15 (3) : 633.
6Elkayam O, Y aron I, Shirazi I, et al. Active leflunomide metabolite inhibits interleukin lbeta, tumour necrosis factor alpha, nitric oxide and metalloprotein- ase-3 in activated human synovial tissue cultures[J]. Ann Rheum Dis, 2003, 62(5) :440-443.
7陈琳 张恩娟 张喆 等.来氟米特致间质性肺炎继发死亡1例.Chinese Journal of Drug Application and Monitoring,2009,6(4):250-256.
8Pinto P,Dougados M.Leflunomide in clinical practice[J].Acta Reumatol Port,2006,31(3):215-224.
9Carulli MT,Davies UM.Peripheral neuropathy:an unwanted effect of leflunomide?[J].Rheumatology,2002,41 (8):952-953.
10Antonio-Valdiviezo A,Pe(n)a-Santos G,Mart(i)nez-Torres J.Peripheral neuropathy caused by leflunomide.A case reported with a brief review[J].Rev Med Inst Mex Seguro Soc,2010,48(5):567-570.
